EP1035197B2 - Produktionsverfahren für Waschmitteltablette - Google Patents

Produktionsverfahren für Waschmitteltablette Download PDF

Info

Publication number
EP1035197B2
EP1035197B2 EP99870039A EP99870039A EP1035197B2 EP 1035197 B2 EP1035197 B2 EP 1035197B2 EP 99870039 A EP99870039 A EP 99870039A EP 99870039 A EP99870039 A EP 99870039A EP 1035197 B2 EP1035197 B2 EP 1035197B2
Authority
EP
European Patent Office
Prior art keywords
tablet
acid
detergent
detergent composition
tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP99870039A
Other languages
English (en)
French (fr)
Other versions
EP1035197A1 (de
EP1035197B1 (de
Inventor
David William Ingram
Ingrid Maria Willems
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8243804&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP1035197(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Priority to ES99870039T priority Critical patent/ES2177212T3/es
Priority to EP99870039A priority patent/EP1035197B2/de
Priority to DE1999601873 priority patent/DE69901873T3/de
Priority to JP2000602741A priority patent/JP2002538269A/ja
Priority to PCT/US2000/005292 priority patent/WO2000052129A1/en
Priority to EP00914783A priority patent/EP1159394A1/de
Priority to US09/914,493 priority patent/US6846794B1/en
Priority to CA002362954A priority patent/CA2362954A1/en
Priority to BR0008775-0A priority patent/BR0008775A/pt
Priority to CN 00807115 priority patent/CN1425059A/zh
Priority to AU36128/00A priority patent/AU3612800A/en
Priority to ARP000100959 priority patent/AR022826A1/es
Publication of EP1035197A1 publication Critical patent/EP1035197A1/de
Publication of EP1035197B1 publication Critical patent/EP1035197B1/de
Publication of EP1035197B2 publication Critical patent/EP1035197B2/de
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/0047—Detergents in the form of bars or tablets
    • C11D17/0065—Solid detergents containing builders
    • C11D17/0073—Tablets
    • C11D17/0091—Dishwashing tablets
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/0047—Detergents in the form of bars or tablets
    • C11D17/0065—Solid detergents containing builders
    • C11D17/0073—Tablets

Definitions

  • the present invention relates to a process for producing detergent tablets.
  • Detergent tablets are now widely used in auto-dish washing application, and are starting to be used in laundry applications. These tablets are produced by industrial processes which typically involve compressing a particulate material into a tablet form, the particulate material being typically formed from a detergent composition.
  • the present invention concerns a process for making a detergent tablet, the process comprising a first step of providing a detergent composition, a second step of forming a particulate material comprising the detergent composition, and a third step of compressing the particulate material in a tablet form.
  • a process for making a detergent tablet comprising a first step of providing a detergent composition, a second step of forming a particulate material comprising the detergent composition, and a third step of compressing the particulate material in a tablet form.
  • Such a process is known from EP-A2-0 711 828 .
  • the detergent tablets obtained by such processes have disadvantages.
  • the compression of the particulate material leads to dissolution characteristics which are difficult to maintain compared to detergent compositions in a fluid form.
  • the invention seeks to provide a process for making a detergent tablet of the above mentioned kind which leads to detergent tablets having improved dissolution characteristics, while maintaining the mechanical integrity of the tablets.
  • this object is accomplished in a process of the above mentioned kind as defined in claim 1, which further comprises a step of cooling the detergent composition below ambient temperature between the first and the third step.
  • the invention relates to a process for making a detergent tablet.
  • a tablet it should be understood a solid block, which may take various shapes, and have various sizes.
  • a detergent tablet it should be understood a tablet containing detergent, i.e. typically containing surfactants. This type of tablet is usually used for cleaning purposes.
  • the process of the invention comprises a first step of providing a detergent composition.
  • the detergent composition may be provided in various forms, and comprise a mixture of different materials.
  • the process also comprises a second step of forming a particulate material comprising the detergent composition, wherein a mix of some, or all of, the components of the particulate material are sprayed with non-gelling binder.
  • the particulate material may be formed in different ways, which are exemplified below. It should be noted that the particulate material comprises the detergent composition but may also comprise other ingredients.
  • the process further comprises a third step of compressing the particulate material in a tablet form. Again, various ways to obtain a tablet by compressing a particulate material are described hereby, although other ways may be useful.
  • the process is characterised in that it further comprises a step of cooling the detergent composition below ambient temperature between the first and the third step.
  • the ambient temperature is considered to be the ambient temperature on the production side in the tabletting area.
  • this ambient temperature is the ambient temperature in the surroundings of the tabletting machine.
  • the ambient temperature of a production site can reach relatively high temperatures, often above 25°C, sometimes above 30°C.
  • the process according to the invention was found particularly useful in such high temperature environments. Indeed, in a preferred embodiment, the ambient temperature is of more than 18°C, even more preferably of more than 20°C.
  • the cooling may take place anytime between the first and third step, for example in storage silos, in spray drum machines, in Loedige KM machines, or during storage between the second and the third step for example.
  • the step of cooling the detergent composition consists in exposing the detergent composition to a temperature below ambient temperature in a portion of space.
  • other means of cooling may also be used, such as de-pressurisation for example.
  • the exposition is provided by placing or displacing the detergent composition in or through the portion of space in which the temperature is below ambient temperature for a given exposition time.
  • This may be achieved for example by placing the detergent composition in a silo, whereby the temperature inside of the silo is below ambient temperature, or by displacing the detergent composition through a cooling tunnel at some stage during the process, or simply by having a cooling air current situated on the production line. Cooling may also be provided by means of liquid nitrogen or solid CO 2 , the advantage of the use of such products being that they are chemically neutral as they normally do not react with a detergent composition, and that they are vaporising as soon as released in the ambient temperature.
  • the process according to the invention was found particularly useful for cooling a detergent composition which is at a temperature above ambient temperature prior to the cooling step. Indeed, even though the ambient temperature will lower the temperature of the detergent composition having a temperature above ambient, such a detergent composition will be cooled faster by applying a temperature under ambient temperature as described in the process of the invention.
  • This particular aspect may be useful in a wide range of ambient temperature, i.e. an ambient temperature of at least 5°C, more preferably of at least 10°C, and even more preferably of at least 15°C.
  • the cooling step is rendered even more efficient when the cooling is provided by a stream, the stream being formed either by projecting a liquid (N 2 for example) or gaseous (air for example) fluid , or even solid such as CO 2 onto the detergent composition, or by having the detergent composition displaced through such a fluid, or by a combination of both, in order to increase the heat transfer between the cooling gaseous or liquid fluid and the detergent composition.
  • the process according to the invention is preferred when the difference of temperature between the ambient temperature and the temperature below ambient temperature is of at least 3°C, more preferably of at least 5°C. It is even more preferred with a difference of at least 10°C.
  • the exposition time is proportional to the weight of detergent composition exposed divided by the difference of temperature between the ambient temperature and the temperature below ambient temperature of the cooling step.
  • the detergent composition is preferably exposed for 30 seconds to a steam of liquid nitrogen, the steam of liquid nitrogen having a debit of from 2 and up to 10 tons per hour.
  • the detergent composition comprises at least 10% by weight of surfactant, more preferably at least 15% of surfactant, even more preferably more than 20% of surfactant, or at least 2% by weight of binder, more preferably at least 3% of binder, even more preferably at least 5% of binder and most preferably at least 7% of binder.
  • surfactant more preferably at least 15% of surfactant, even more preferably more than 20% of surfactant, or at least 2% by weight of binder, more preferably at least 3% of binder, even more preferably at least 5% of binder and most preferably at least 7% of binder.
  • the detergent composition has a temperature below ambient temperature after the cooling step and before the third step, this being due to the cooling of the detergent composition.
  • the detergent composition has a temperature of at least 2°C below ambient temperature, more preferably 5°C and most preferably 10°C.
  • a tablet obtainable by the process of the invention was found to dispense more readily.
  • the tablets may comprise components such as fragrance, surfactants, enzymes, detergent etc....
  • Typical tablet compositions for the preferred embodiment of the present invention are disclosed in the pending European applications of the Applicant EP-A-846755 , EP-A-846798 , EP-A-846756 and EP-A-846754 . for example.
  • Elements typically entering in the composition of detergent tablets or of other forms detergents such as liquids or granules are detailed in the following paragraphs.
  • the tablet may comprise a highly soluble compound.
  • a highly soluble compound is defined as follow:
  • a solution is prepared as follows comprising de-ionised water as well as 20 grams per litre of a specific compound:
  • the specific compound is highly soluble according to the invention when the conductivity of the solution reaches 80% of its maximum value in less than 10 seconds, starting from the complete addition of the de-ionised water to the compound. Indeed, when monitoring the conductivity in such a manner, the conductivity reaches a plateau after a certain period of time, this plateau being considered as the maximum value.
  • Such a compound is preferably in the form of a flowable material constituted of solid particles at temperatures comprised between 10 and 80°Celsius for ease of handling, but other forms may be used such as a paste or a liquid.
  • Example of highly soluble compounds include Sodium di isoalkylbenzene sulphonate (DIBS) or Sodium toluene sulphonate for example.
  • the tablet may comprise a compound having a Cohesive Effect on the particulate material of a detergent matrix forming the tablet.
  • the Cohesive Effect on the particulate material of a detergent matrix forming the tablet or a layer of the tablet is characterised by the force required to break a tablet or layer based on the examined detergent matrix pressed under controlled compression conditions. For a given compression force, a high tablet or layer strength indicates that the granules stuck highly together when they were compressed, so that a strong cohesive effect is taking place.
  • Means to assess tablet or layer strength are given in Pharmaceutical dosage forms : tablets volume 1 Ed. H.A. Lieberman et al, published in 1989.
  • the cohesive effect is measured by comparing the tablet or layer strength of the original base powder without compound having a cohesive effect with the tablet or layer strength of a powder mix which comprises 97 parts of the original base powder and 3 parts of the compound having a cohesive effect.
  • the compound having a cohesive effect is preferably added to the matrix in a form in which it is substantially free of water (water content below 10% (pref. below 5%)).
  • the temperature of the addition is between 10 and 80C, more pref. between 10 and 40C.
  • a compound is defined as having a cohesive effect on the particulate material according to the invention when at a given compacting force of 3000N, tablets with a weight of 50g of detergent particulate material and a diameter of 55mm have their tablet tensile strength increased by over 30% (preferably 60 and more preferably 100%) by means of the presence of 3% of the compound having a cohesive effect in the base particulate material.
  • An example of a compound having a cohesive effect is Sodium di isoalkylbenzene sulphonate.
  • the dissolution of the tablet or layer in an aqueous solution is significantly increased.
  • at least 0.5% per weight of a tablet or layer is formed from the highly soluble compound, more preferably at least 0.75%, even more preferably at least 2% and most preferably at least 4% per weight of the tablet or layer being formed from the highly soluble compound having a cohesive effect on the particulate material.
  • composition comprising a highly soluble compound as well as a surfactant is disclosed in EP-A-0 524 075 , this composition being a liquid composition.
  • a highly soluble compound having a cohesive effect on the particulate material allows to obtain a tablet having a higher tensile strength at constant compacting force or an equal tensile strength at lower compacting force when compared to traditional tablets.
  • a whole tablet will have a tensile strength of more than 5kPa, preferably of more than 10kPa, more preferably, in particular for use in laundry applications, of more than 15kPa, even more preferably of more than 30 kPa and most preferably of more than 50 kPa, in particular for use in dish washing or auto dish washing applications; and a tensile strength of less than 300 kPa, preferably of less than 200 kPa, more preferably of less than 100 kPa, even more preferably of less than 80 kPa and most preferably of less than 60 kPa.
  • the tablets should be less compressed than in case of auto dish washing applications for example, whereby the dissolution is more readily achieved, so that in a laundry application
  • the tablet may comprise several layers.
  • the layer may be considered as a tablet itself.
  • Detergent tablets can be prepared simply by mixing the solid ingredients together and compressing the mixture in a conventional tablet press as used, for example, in the pharmaceutical industry.
  • the principal ingredients in particular gelling surfactants, are used in particulate form.
  • Any liquid ingredients, for example surfactant or suds suppressor, can be incorporated in a conventional manner into the solid particulate ingredients.
  • the ingredients such as builder and surfactant can be spray-dried in a conventional manner and then compacted at a suitable pressure.
  • the tablets according to the invention are compressed using a force of less than 100000N, more preferably of less than 50000N, even more preferably of less than 5000N and most preferably of less than 3000 N.
  • the most preferred embodiment is a tablet suitable for laundry compressed using a force of less than 2500N, but tablets for auto dish washing may also be considered for example, whereby such auto dish washing tablets are usually more compressed than laundry tablets.
  • the particulate material used for making a tablet can be made by any particulation or granulation process.
  • An example of such a process is spray drying (in a co-current or counter current spray drying tower) which typically gives low bulk densities 600g/l or lower.
  • Particulate materials of higher density can be prepared by granulation and densification in a high shear batch mixer/granulator or by a continuous granulation and densification process (e.g. using Lodige® CB and/or Lodige® KM mixers).
  • Other suitable processes include fluid bed processes, compaction processes (e.g. roll compaction), extrusion, as well as any particulate material made by any chemical process like flocculation, crystallisation sentering, etc.
  • Individual particles can also be any other particle, granule, sphere or grain.
  • the components of the particulate material may be mixed together by any conventional means. Batch is suitable in, for example, a concrete mixer, Nauta mixer, ribbon mixer or any other. Alternatively the mixing process may be carried out continuously by metering each component by weight on to a moving belt, and blending them in one or more drum(s) or mixer(s).
  • Non-gelling binder is sprayed on to the mix of some, or all of, the components of the particulate material.
  • Other liquid ingredients may also be sprayed on to the mix of components either separately or premixed. For example perfume and slurries of optical brighteners may be sprayed.
  • a finely divided flow aid dustting agent such as zeolites, carbonates, silicas
  • the tablets may be manufactured by using any compacting process, such as tabletting, briquetting, or extrusion, preferably tabletting.
  • Suitable equipment includes a standard single stroke or a rotary press (such as Courtoy®, Korch®,
  • the tablets prepared according to this invention preferably have a diameter of between 20mm and 60mm, preferably of at least 35 and up to 55 mm, and a weight between 25 and 100 g.
  • the ratio of height to diameter (or width) of the tablets is preferably greater than 1:3, more preferably greater than 1:2.
  • the tablets have a square cross-section of 45 mm by 45 mm and are 25 mm high.
  • the compaction pressure used for preparing these tablets need not exceed 100000 kN/m 2 , preferably not exceed 30000 kN/m 2 , more preferably not exceed 5000 kN/m 2 , even more preferably not exceed 3000kN/m 2 and most preferably not exceed 1000kN/m 2 .
  • the tablet has a density of at least 0.9 g/cc, more preferably of at least 1.0 g/cc, and preferably of less than 2.0 g/cc, more preferably of less than 1.5 g/cc, even more preferably of less than 1.25 g/cc and most preferably of less than 1.15 g/cc.
  • Multi layered tablets are typically formed in rotating presses by placing the particulate material of each layer, one after the other in force feeding flasks. As the process continues, the particulate material layers are then pressed together in the pre-compression and compression stages stations to form the multilayer tablet. With some rotating presses it is also possible to compress the first feed layer before compressing the whole tablet.
  • a highly soluble compound having a cohesive effect may be integrated to a detergent tablet, whereby this compound is also a hydrotrope compound.
  • Such hydrotrope compound may be generally used to favour surfactant dissolution by avoiding gelling.
  • a specific compound is defined as being hydrotrope as follows (see S.E. Friberg and M. Chiu, J. Dispersion Science and Technology, 9(5&6), pages 443 to 457, (1988-1989 )):
  • the hydrotrope compound is a flowable material made of solid particles at operating conditions between 15 and 60° Celsius.
  • Hydrotrope compounds include the compounds listed thereafter:
  • Such compound would further increase the dissolution rate of the tablet, as a hydrotrope compound facilitates dissolution of surfactants, for example.
  • a hydrotrope compound facilitates dissolution of surfactants, for example.
  • Such a compound could be formed from a mixture or from a single compound.
  • the layer may be considered as a tablet itself.
  • the used compacting force may be adjusted to not affect the tensile strength, and the disintegration time in the washing machine. This process may be used to prepare homogenous or layered tablets of any size or shape.
  • F is the maximum force (Newton) to cause tensile failure (fracture) measured by a VK 200 tablet hardness tester supplied by Van Kell industries, Inc.
  • D is the diameter of the tablet or layer, and t the thickness of the tablet or layer. For a non round tablet, ⁇ D may simply be replaced by the perimeter of the tablet.
  • a tablet having a diametral fracture stress of less than 20 kPa is considered to be fragile and is likely to result in some broken tablets being delivered-to the consumer.
  • a diametral fracture stress of at least 25 kPa is preferred.
  • the rate of dispensing of a detergent tablet can be determined in the following way:
  • the level of residues is determined by repeating the procedure 10 times and an average residue level is calculated based on the ten individual measurements. In this stressed test a residue of 40 % of the starting tablet weight is considered to be acceptable. A residue of less than 30% is preferred, and less than 25% is more preferred.
  • Detergent tablets may further comprise an effervescent.
  • Effervescency as defined herein means the evolution of bubbles of gas from a liquid, as the result of a chemical reaction between a soluble acid source and an alkali metal carbonate, to produce carbon dioxide gas, i.e. C 6 H 8 O 7 + 3NaHCO 3 ⁇ Na 3 C 6 H 5 O 7 + 3CO 2 ⁇ + 3H 2 O
  • An effervescent may be added to the tablet mix in addition to the detergent ingredients.
  • the addition of this effervescent to the detergent tablet improves the disintegration time of the tablet.
  • the amount will preferably be between 5 and 20 % and most preferably between 10 and 20% by weight of the tablet.
  • the effervescent should be added as an agglomerate of the different particles or as a compact, and not as separated particles.
  • the tablet Due to the gas created by the effervescency in the tablet, the tablet can have a higher D.F.S. and still have the same disintegration time as a tablet without effervescency.
  • the D.F.S. of the tablet with effervescency is kept the same as a tablet without, the disintegration of the tablet with effervescency will be faster.
  • dissolution aid could be provided by using compounds such as sodium acetate or urea.
  • suitable dissolution aid may also be found in Pharmaceutical Dosage Forms: Tablets, Volume 1, Second edition, Edited by H.A. Lieberman et all, ISBN 0-8247-8044-2 .
  • Solidity of a tablet may be improved by making a coated tablet, the coating covering a non-coated tablet, thereby improving the mechanical characteristics of the tablet.
  • the tablets may then be coated so that the tablet does not absorb moisture, or absorbs moisture at only a very slow rate.
  • the coating is also strong so that moderate mechanical shocks to which the tablets are subjected during handling, packing and shipping result in no more than very low levels of breakage or attrition.
  • the coating is preferably brittle so that the tablet breaks up quickly when subjected to stronger mechanical shock.
  • the coating material is dissolved under alkaline conditions, or is readily emulsified by surfactants. This contributes to avoiding the problem of visible residue in the window of a front-loading washing machine during the wash cycle, and also avoids deposition of undissolved particles or lumps of coating material on the laundry load.
  • Water solubility is measured following the test protocol of ASTM E1148-87 entitled, "Standard Test Method for Measurements of Aqueous Solubility".
  • the coating material has a melting point preferably of from 40 °C to 200 °C.
  • the coating can be applied in a number of ways. Two preferred coating methods are a) coating with a molten material and b) coating with a solution of the material.
  • the coating material is applied at a temperature above its melting point, and solidifies on the tablet.
  • the coating is applied as a solution, the solvent being dried to leave a coherent coating.
  • the substantially insoluble material can be applied to the tablet by, for example, spraying or dipping. Normally when the molten material is sprayed on to the tablet, it will rapidly solidify to form a coherent coating. When tablets are dipped into the molten material and then removed, the rapid cooling again causes rapid solidification of the coating material. During the solidification phase, the coating undergoes some internal stress (e.g. shrinkage upon cooling) and external stress (e.g. tablet relaxation).
  • the coating comprises a component which is liquid at 25°C. It is believed that this liquid component will allow the coating to better withstand and absorb mechanical stress by rendering the coating structure more flexible.
  • the component which is liquid at 25°C is preferably added to the coating materials in proportions of less than 10% by weight of the coating, more preferably less than 5% by weight, and most preferably of less than 3% by weight.
  • the component which is liquid at 25°C is preferably added to the coating materials in proportions of more than 0.1% by weight of the coating, more preferably more than 0.3% by weight, and most preferably of more than 0.5% by weight. Further preferred is the addition of reinforcing fibres to the coating in order to further reinforce the structure.
  • the coating comprises a crystallised structure.
  • crystallised it should be understood that the coating comprises a material which is solid at ambient temperature (25°C) and has a structure exhibiting some order. This can be detected typically by usual crystallography techniques e.g. X-ray analysis, on the material itself.
  • the material forming the crystallised structure does not co-crystallised or only partially with the optional component which is liquid at 25°C mentioned above. Indeed, it is preferred that the optional component remains in the liquid state at 25°C in the coating crystalline structure in order to provide flexibility to the structure and resistance to mechanical stress.
  • the optional component which is liquid at 25°C may advantageously have a functionality in the washing of laundry, for example silicone oil which provides suds suppression benefits or perfume oil..
  • the coating may also comprise other optional components.
  • Suitable coating materials are for example dicarboxylic acids.
  • Particularly suitable dicarboxylic acids are selected from the group consisting of oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, pimelic acid, suberic acid, azelaic acid, sebacic acid, undecanedioic acid, dodecanedioic acid, tridecanedioic acid and mixtures thereof. Most preferred is adipic acid.
  • substantially insoluble materials having a melting point below 40 °C are often not sufficiently solid at ambient temperatures and it has been found that materials having a melting point above about 200 °C are not practicable to use.
  • an acid having a melting point of more than 90°C such as azelaic, sebacic acid, dodecanedioic acid is used. It is even more preferred to use an acid having a melting point of more than 145°C such as adipic acid.
  • melting point is meant the temperature at which the material when heated slowly in, for example, a capillary tube becomes a clear liquid.
  • a coating of any desired thickness can be applied according to the present invention.
  • the coating forms from 1% to 10%, preferably from 1.5% to 5%, of the tablet weight.
  • Tablet coatings are very hard and provide extra strength to the tablet.
  • optional components which are liquid at 25° are including PolyEthylene Glycols, thermal oil, silicon oil, esters of dicarboxylic acids, mono carboxylic acids, parafin, triacetin, perfumes or alkaline solutions. It is preferred that the structure of the components which is liquid at 25°C is close to the material forming the crystallised structure, so that the structure is not excessively disrupted.
  • the crystallised structure is made of adipic acid, the component which is liquid at 25°C being available under the name CoasolTM from Chemoxy International, being a blend of the di-isobutyl esters of the glutaric, succinic and adipic acid.
  • CoasolTM from Chemoxy International
  • the advantage of the use of this component being the good dispersion in the adipic acid to provide flexibility. It should be noted that disintegration of the adipic acid is further improved by the adipate content of CoasolTM.
  • Fracture of the coating in the wash can be improved by adding a disintegrant in the coating.
  • This disintegrant will swell once in contact with water and break the coating in small pieces. This will improve the dissolution of the coating in the wash solution.
  • the disintegrant is suspended in the coating melt at a level of up to 30%, preferably between 5% and 20%, most preferably between 5 and 10% by weight. Possible disintegrants are described in Handbook of Pharmaceutical Excipients (1986).
  • Suitable disintegrants include starch: natural, modified or pregelatinized starch, sodium starch gluconate; gum: agar gum, guar gum, locust bean gum, karaya gum, pectin gum, tragacanth gum; croscarmylose Sodium, crospovidone, cellulose, carboxymethyl cellulose, algenic acid and its salts including sodium alginate, silicone dioxide, clay, polyvinylpyrrolidone, soy polysacharides, ion exchange resins, polymers containing cationic (e.g. quaternary ammonium) groups, amine-substituted polyacrylates, polymerised cationic amino acids such as poly-L-lysine, polyallylamine hydrochloride) and mixtures thereof.
  • cationic e.g. quaternary ammonium
  • the coating comprises an acid having a melting temperature of at least 145°C, such as adipic acid for example, as well as a clay, such as a bentonite clay for example, whereby the clay is used as a disintegrant and also to render the structure of adipic acid more favourable for water penetration, thus improving the dispersion of the adipic acid in a aqueous medium.
  • a clay such as a bentonite clay for example
  • bentonite clays are preferred.
  • the acid has a melting point such that traditional cellulosic disintegrants undergo a thermal degradation during the coating process, whereas such clays are found to be more heat stable. Further, traditional cellulosic disintegrant such as NymcelTM for example are found to turn brown at these temperatures.
  • the coating further comprises reinforcing fibres.
  • Such fibres have been found to improve further the resistance of the coating to mechanical stress and minimise the splitting defect occurence.
  • Such fibres are preferably having a length of at least 100 ⁇ m, more preferably of at least 200 ⁇ m and most preferably of at least 250 ⁇ m to allow structure reinforcement.
  • Such fibres are preferably having a length of at less than 500 ⁇ m, more preferably of less than 400 ⁇ m and most preferably of less than 350 ⁇ m in order not to impact onto dispersion of the coating in an aqueous medium.
  • Materials which may be used for these fibres include viscose rayon, natural nylon, synthetic nylon (polyamides types 6 and 6,6), acrylic, polyester, cotton and derivatives of cellulose such as CMCs. Most preferred is a cellulosic material available under the trade mark Solka-FlocTM from Fibers Sales & Development. It should be noted that such fibres do not normally need pre-compression for reinforcing the coating structure. Such fibres are preferably added at a level of less than 5% by weight of the coating, more preferably less than 3% by weight. Such fibres are preferably added at a level of more than 0.5% by weight of the coating, more preferably more than 1% by weight.
  • Surfactant are typically comprised in a detergent composition.
  • the dissolution of surfactants is favoured by the addition of the highly soluble compound.
  • Nonlimiting examples of surfactants useful herein typically at levels from about 1% to about 55%, by weight include the conventional C 11- C 18 alkyl benzene sulfonates ("LAS") and primary, branched-chain and random C 10- C 20 alkyl sulfates (“AS”), the C 10- C 18 secondary (2,3) alkyl sulfates of the formula CH 3 (CH 2 ) x (CHOSO 3- M + ) CH 3 and CH 3 (CH 2 ) y (CHOSO 3- M + ) CH 2 CH 3 where x and (y + 1) are integers of at least about 7, preferably at least about 9, and M is a water-solubilizing cation, especially sodium, unsaturated sulfates such as oleyl sulfate, the C 10- C 18 alkyl alkoxy sulfates (“AE X S”; especially EO 1-7 ethoxy sulfates), C 10- C 18 alkyl alkoxy carboxylates (especially the EO 1-5
  • the conventional nonionic and amphoteric surfactants such as the C 12- C 18 alkyl ethoxylates ("AE") including the so-called narrow peaked alkyl ethoxylates and C 6 -C 12 alkyl phenol alkoxylates (especially ethoxylates and mixed ethoxy/propoxy), C 12- C 18 betaines and sulfobetaines ("sultaines"), C 10- C 18 amine oxides, and the like, can also be included in the overall compositions.
  • the C 10 -C 18 N-alkyl polyhydroxy fatty acid amides can also be used. Typical examples include the C 12 -C 18 N-methylglucamides. See WO 9,206,154 .
  • sugar-derived surfactants include the N-alkoxy polyhydroxy fatty acid amides, such as C 10 -C 18 N-(3-methoxypropyl) glucamide.
  • the N-propyl through N-hexyl C 12 -C 18 glucamides can be used for low sudsing.
  • C 10 -C 20 conventional soaps may also be used. If high sudsing is desired, the branched-chain C 10 -C 16 soaps may be used. Mixtures of anionic and nonionic surfactants are especially useful.
  • the tablet comprises at least 5% per weight of surfactant, more preferably at least 15% per weight, even more preferably at least 25% per weight, and most preferably between 35% and 45% per weight of surfactant.
  • Non gelling binders are integrated in detergent compositions to further facilitate dissolution.
  • Suitable non-gelling binders include synthetic organic polymers such as polyethylene glycols, polyvinylpyrrolidones, polyacrylates and water-soluble acrylate copolymers.
  • the handbook of Pharmaceutical Excipients second edition has the following binders classification: Acacia, Alginic Acid, Carbomer, Carboxymethylcellulose sodium, Dextrin, Ethylcellulose, Gelatin, Guar gum, Hydrogenated vegetable oil type I, Hydroxyethyl cellulose, Hydroxypropyl methylcellulose, Liquid glucose, Magnesium aluminum silicate, Maltodextrin, Methylcellulose, polymethacrylates, povidone, sodium alginate, starch and zein.
  • binders also have an active cleaning function in the laundry wash such as cationic polymers, i.e. ethoxylated hexamethylene diamine quaternary compounds, bishexamethylene triamines, or others such as pentaamines, ethoxylated polyethylene amines, maleic acrylic polymers.
  • cationic polymers i.e. ethoxylated hexamethylene diamine quaternary compounds, bishexamethylene triamines, or others such as pentaamines, ethoxylated polyethylene amines, maleic acrylic polymers.
  • Non-gelling binder materials are sprayed on and hence have an appropriate melting point temperature below 90°C, preferably below 70°C and even more preferably below 50°C so as not to damage or degrade the other active ingredients in the matrix.
  • non-aqueous liquid binders i.e. not in aqueous solution
  • they may also be solid binders incorporated into the matrix by dry addition but which have binding properties within the tablet.
  • Non-gelling binder materials are preferably used in an amount within the range from 0.1 to 15% of the composition, more preferably below 5% and especially if it is a non laundry active material below 4% by weight of the tablet.
  • gelling binders such as nonionic surfactants are avoided in their liquid or molten form.
  • Nonionic surfactants and other gelling binders are not excluded from the compositions, but it is preferred that they be processed into the detergent tablets as components of particulate materials, and not as liquids.
  • Detergent builders can optionally be included in the compositions herein to assist in controlling mineral hardness. Inorganic as well as organic builders can be used. Builders are typically used in fabric laundering compositions to assist in the removal of particulate soils.
  • Inorganic or P-containing detergent builders include, but are not limited to, the alkali metal, ammonium and alkanolammonium salts of polyphosphates (exemplified by the tripolyphosphates, pyrophosphates, and glassy polymeric meta-phosphates), phosphonates, phytic acid, silicates, carbonates (including bicarbonates and sesquicarbonates), sulphates, and aluminosilicates.
  • compositions herein function surprisingly well even in the presence of the so-called “weak” builders (as compared with phosphates) such as citrate, or in the so-called "underbuilt” situation that may occur with zeolite or layered silicate builders.
  • silicate builders are the alkali metal silicates, particularly those having a SiO 2 :Na 2 O ratio in the range 1.6:1 to 3.2:1 and layered silicates, such as the layered sodium silicates described in U.S. Patent 4,664,839, issued May 12, 1987 to H. P. Rieck.
  • NaSKS-6 is the trademark for a crystalline layered silicate marketed by Hoechst (commonly abbreviated herein as "SKS-6").
  • Hoechst commonly abbreviated herein as "SKS-6”
  • the Na SKS-6 silicate builder does not contain aluminum.
  • NaSKS-6 has the delta-Na 2 SiO 5 morphology form of layered silicate.
  • SKS-6 is a highly preferred layered silicate for use herein, but other such layered silicates, such as those having the general formula NaMSi x O 2x+1 ⁇ yH 2 O wherein M is sodium or hydrogen, x is a number from 1.9 to 4, preferably 2, and y is a number from 0 to 20, preferably 0 can be used herein.
  • Various other layered silicates from Hoechst include NaSKS-5, NaSKS-7 and NaSKS-11, as the alpha, beta and gamma forms.
  • delta-Na 2 SiO 5 (NaSKS-6 form) is most preferred for use herein.
  • Other silicates may also be useful such as for example magnesium silicate, which can serve as a crispening agent in granular formulations, as a stabilizing agent for oxygen bleaches, and as a component of suds control systems.
  • carbonate builders are the alkaline earth and alkali metal carbonates as disclosed in German Patent Application No. 2,321,001 published on November 15, 1973.
  • Aluminosilicate builders are useful in the present invention.
  • Aluminosilicate builders are of great importance in most currently marketed heavy duty granular detergent compositions, and can also be a significant builder ingredient in liquid detergent formulations.
  • Aluminosilicate builders include those having the empirical formula: M z (zAlO 2 ) y ] ⁇ xH 2 O wherein z and y are integers of at least 6, the molar ratio of z to y is in the range from 1.0 to about 0.5, and x is an integer from about 15 to about 264.
  • aluminosilicate ion exchange materials are commercially available. These aluminosilicates can be crystalline or amorphous in structure and can be naturally-occurring aluminosilicates or synthetically derived. A method for producing aluminosilicate ion exchange materials is disclosed in U.S. Patent 3,985,669 , Krummel, et al, issued October 12, 1976. Preferred synthetic crystalline aluminosilicate ion exchange materials useful herein are available under the designations Zeolite A, Zeolite P (B), Zeolite MAP and Zeolite X.
  • the crystalline aluminosilicate ion exchange material has the formula: Na 12 [(AlO 2 ) 12 (SiO 2 ) 12 ] ⁇ xH 2 O wherein x is from about 20 to about 30, especially about 27.
  • This material is known as Zeolite A.
  • the aluminosilicate has a particle size of about 0.1-10 microns in diameter.
  • Organic detergent builders suitable for the purposes of the present invention include, but are not restricted to, a wide variety of polycarboxylate compounds.
  • polycarboxylate refers to compounds having a plurality of carboxylate groups, preferably at least 3 carboxylates.
  • Polycarboxylate builder can generally be added to the composition in acid form, but can also be added in the form of a neutralized salt. When utilized in salt form, alkali metals, such as sodium, potassium, and lithium, or alkanolammonium salts are preferred.
  • polycarboxylate builders include a variety of categories of useful materials.
  • One important category of polycarboxylate builders encompasses the ether polycarboxylates, including oxydisuccinate, as disclosed in Berg, U.S. Patent 3,128,287, issued April 7, 1964 , and Lamberti et al, U.S. Patent 3,635,830, issued January 18, 1972 . See also "TMS/TDS" builders of U.S. Patent 4,663,071 , issued to Bush et al, on May 5, 1987.
  • Suitable ether polycarboxylates also include cyclic compounds, particularly alicyclic compounds, such as those described in U.S. Patents 3,923,679 ; 3,835,163 ; 4,158,635 ; 4,120,874 and 4,102,903 .
  • ether hydroxypolycarboxylates copolymers of maleic anhydride with ethylene or vinyl methyl ether, 1, 3, 5-trihydroxy benzene-2, 4, 6-trisulphonic acid, and carboxymethyloxysuccinic acid
  • various alkali metal, ammonium and substituted ammonium salts of polyacetic acids such as ethylenediamine tetraacetic acid and nitrilotriacetic acid
  • polycarboxylates such as mellitic acid, succinic acid, oxydisuccinic acid, polymaleic acid, benzene 1,3,5-tricarboxylic acid, carboxymethyloxysuccinic acid, and soluble salts thereof.
  • Citrate builders e.g., citric acid and soluble salts thereof (particularly sodium salt), are polycarboxylate builders of particular importance for heavy duty liquid detergent formulations due to their availability from renewable resources and their biodegradability. Citrates can also be used in granular compositions, especially in combination with zeolite and/or layered silicate builders. Oxydisuccinates are also especially useful in such compositions and combinations.
  • succinic acid builders include the C 5 -C 20 alkyl and alkenyl succinic acids and salts thereof.
  • a particularly preferred compound of this type is dodecenylsuccinic acid.
  • succinate builders include: laurylsuccinate, myristylsuccinate, palmitylsuccinate, 2-dodecenylsuccinate (preferred), 2-pentadecenylsuccinate, and the like. Laurylsuccinates are the preferred builders of this group, and are described in European Patent Application 86200690.5/0,200,263 , published November 5, 1986.
  • Fatty acids e.g., C 12 -C 18 monocarboxylic acids
  • the aforesaid builders especially citrate and/or the succinate builders, to provide additional builder activity.
  • Such use of fatty acids will generally result in a diminution of sudsing, which should be taken into account by the formulator.
  • the various alkali metal phosphates such as the well-known sodium tripolyphosphates, sodium pyrophosphate and sodium orthophosphate can be used.
  • Phosphonate builders such as ethane-1-hydroxy-1,1-diphosphonate and other known phosphonates (see, for example, U.S. Patents 3,159,581 ; 3,213,030 ; 3,422,021 ; 3,400,148 and 3,422,137 ) can also be used.
  • the detergent compositions herein may optionally contain bleaching agents or bleaching compositions containing a bleaching agent and one or more bleach activators.
  • bleaching agents will typically be at levels of from about 1% to about 30%, more typically from about 5% to about 20%, of the detergent composition, especially for fabric laundering.
  • the amount of bleach activators will typically be from about 0.1% to about 60%, more typically from about 0.5% to about 40% of the bleaching composition comprising the bleaching agent-plus-bleach activator.
  • the bleaching agents used herein can be any of the bleaching agents useful for detergent compositions in textile cleaning, hard surface cleaning, or other cleaning purposes that are now known or become known. These include oxygen bleaches as well as other bleaching agents.
  • Perborate bleaches e.g., sodium perborate (e.g., mono- or tetra-hydrate) can be used herein.
  • bleaching agent that can be used without restriction. encompasses percarboxylic acid bleaching agents and salts thereof. Suitable examples of this class of agents include magnesium monoperoxyphthalate hexahydrate, the magnesium salt of metachloro perbenzoic acid, 4-nonylamino-4-oxoperoxybutyric acid and diperoxydodecanedioic acid.
  • Such bleaching agents are disclosed in U.S. Patent 4,483,781 , Hartman, issued November 20, 1984, U.S. Patent Application 740,446 , Burns et al, filed June 3, 1985, European Patent Application 0,133,354 , Banks et al, published February 20, 1985, and U.S.
  • Patent 4,412,934 Chung et al, issued November 1, 1983.
  • Highly preferred bleaching agents also include 6-nonylamino-6-oxoperoxycaproic acid as described in U.S. Patent 4,634,551, issued January 6, 1987 to Burns et al.
  • Peroxygen bleaching agents can also be used. Suitable peroxygen bleaching compounds include sodium carbonate peroxyhydrate and equivalent "percarbonate” bleaches, sodium pyrophosphate peroxyhydrate, urea peroxyhydrate, and sodium peroxide. Persulfate bleach (e.g., OXONE, manufactured commercially by DuPont) can also be used.
  • a preferred percarbonate bleach comprises dry particles having an average particle size in the range from about 500 micrometers to about 1,000 micrometers, not more than about 10% by weight of said particles being smaller than about 200 micrometers and not more than about 10% by weight of said particles being larger than about 1,250 micrometers.
  • the percarbonate can be coated with silicate, borate or water-soluble surfactants.
  • Percarbonate is available from various commercial sources such as FMC, Solvay and Tokai Denka.
  • Mixtures of bleaching agents can also be used.
  • Peroxygen bleaching agents, the perborates, the percarbonates, etc. are preferably combined with bleach activators, which lead to the in situ production in aqueous solution (i.e., during the washing process) of the peroxy acid corresponding to the bleach activator.
  • bleach activators Various nonlimiting examples of activators are disclosed in U.S. Patent 4,915,854, issued April 10, 1990 to Mao et al, and U.S. Patent 4,412,934 .
  • the nonanoyloxybenzene sulfonate (NOBS) and tetraacetyl ethylene diamine (TAED) activators are typical, and mixtures thereof can also be used. See also U.S. 4,634.551 for other typical bleaches and activators useful herein.
  • amido-derived bleach activators are those of the formulae: R 1 N(R 5 )C(O)R 2 C(O)L or R 1 C(O)N(R 5 )R 2 C(O)L wherein R 1 is an alkyl group containing from about 6 to about 12 carbon atoms, R 2 is an alkylene containing from 1 to about 6 carbon atoms, R 5 is H or alkyl, aryl, or alkaryl containing from about 1 to about 10 carbon atoms, and L is any suitable leaving group.
  • a leaving group is any group that is displaced from the bleach activator as a consequence of the nucleophilic attack on the bleach activator by the perhydrolysis anion.
  • a preferred leaving group is phenyl sulfonate.
  • bleach activators of the above formulae include (6-octanamido-caproyl)oxybenzenesulfonate, (6-nonanamidocaproyl)oxybenzene-sulfonate, (6-decanamido-caproyl)oxybenzenesulfonate, and mixtures thereof as described in U.S. Patent 4,634,551 .
  • Another class of bleach activators comprises the benzoxazin-type activators disclosed by Hodge et al in U.S. Patent 4,966,723, issued October 30, 1990 .
  • a highly preferred activator of the benzoxazin-type is:
  • Still another class of preferred bleach activators includes the acyl lactam activators, especially acyl caprolactams and acyl valerolactams of the formulae: wherein R 6 is H or an alkyl, aryl, alkoxyaryl, or alkaryl group containing from 1 to about 12 carbon atoms.
  • lactam activators include benzoyl caprolactam, octanoyl caprolactam, 3,5,5-trimethylhexanoyl caprolactam, nonanoyl caprolactam, decanoyl caprolactam, undecenoyl caprolactam, benzoyl valerolactam, octanoyl valerolactam, decanoyl valerolactam, undecenoyl valerolactam, nonanoyl valerolactam, 3,5,5-trimethylhexanoyl valerolactam and mixtures thereof. See also U.S. Patent 4,545,784 , issued to Sanderson, October 8, 1985, which discloses acyl caprolactams, including benzoyl caprolactam, adsorbed into sodium perborate.
  • Bleaching agents other than oxygen bleaching agents are also known in the art and can be utilized herein.
  • One type of non-oxygen bleaching agent of particular interest includes photoactivated bleaching agents such as the sulfonated zinc and/or aluminum phthalocyanines. See U.S. Patent 4,033,718, issued July 5, 1977 to Holcombe et al. If used, detergent compositions will typically contain from about 0.025% to about 1.25%, by weight, of such bleaches, especially sulfonate zinc phthalocyanine.
  • the bleaching compounds can be catalyzed by means of a manganese compound.
  • a manganese compound Such compounds are well known in the art and include, for example, the manganese-based catalysts disclosed in U.S. Pat. 5,246,621 , U.S. Pat. 5,244,594 ; U.S. Pat. 5,194,416 ; U.S. Pat. 5,114,606 ; and European Pat. App. Pub. Nos.
  • Preferred examples of these catalysts include Mn IV 2 (u-O) 3 (1,4,7-trimethyl-1,4,7-triazacyclononane) 2 (PF 6 ) 2 , Mn III 2 (u-O) 1 (u-OAc) 2 (1,4,7-trimethyl-1,4,7-triazacyclononane) 2 -(ClO 4 ) 2 , Mn IV 4 (u-O) 6 (1,4,7-triazacyclononane) 4 (ClO 4 ) 4 , Mn III Mn IV 4 (u-O) 1 (u-OAc) 2- (1,4,7-trimethyl-1,4,7-triazacyclononane) 2 (ClO 4 ) 3 , Mn IV (1,4,7-trimethyl-1,4,7-triazacyclononane)-(OCH 3 ) 3 (PF 6 ), and
  • metal-based bleach catalysts include those disclosed in U.S. Pat. 4,430,243 and U.S. Pat. 5,114,611 .
  • the use of manganese with various complex ligands to enhance bleaching is also reported in the following United States Patents: 4,728,455 ; 5,284,944; 5,246,612; 5,256,779 ; 5,280,117; 5,274,147 ; 5,153,161 ; and 5,227,084 .
  • compositions and processes herein can be adjusted to provide on the order of at least one part per ten million of the active bleach catalyst species in the aqueous washing liquor, and will preferably provide from about 0.1 ppm to about 700 ppm, more preferably from about 1 ppm to about 500 ppm, of the catalyst species in the laundry liquor.
  • Enzymes can be included in the formulations herein for a wide variety of fabric laundering purposes, including removal of protein-based, carbohydrate-based, or triglyceride-based stains, for example, and for the prevention of refugee dye transfer, and for fabric restoration.
  • the enzymes to be incorporated include proteases, amylases, lipases, cellulases, and peroxidases, as well as mixtures thereof.
  • Other types of enzymes may also be included. They may be of any suitable origin, such as vegetable, animal, bacterial, fungal and yeast origin. However, their choice is governed by several factors such as pH-activity and/or stability optima, thermostability, stability versus active detergents, builders and so on. In this respect bacterial or fungal enzymes are preferred, such as bacterial amylases and proteases, and fungal cellulases.
  • Enzymes are normally incorporated at levels sufficient to provide up to about 5 mg by weight, more typically about 0.01 mg to about 3 mg, of active enzyme per gram of the composition. Stated otherwise, the compositions herein will typically comprise from about 0.001% to about 5%, preferably 0.01%-1% by weight of a commercial enzyme preparation. Protease enzymes are usually present in such commercial preparations at levels sufficient to provide from 0.005 to 0.1 Anson units (AU) of activity per gram of composition.
  • AU Anson units
  • proteases are the subtilisins which are obtained from particular strains of B. subtilis and B. licheniforms. Another suitable protease is obtained from a strain of Bacillus, having maximum activity throughout the pH range of 8-12, developed and sold by Novo Industries A/S under the registered trade name ESPERASE. The preparation of this enzyme and analogous enzymes is described in British Patent Specification No. 1,243,784 of Novo.
  • protealytic enzymes suitable for removing protein-based stains that are commercially available include those sold under the tradenames ALCALASE and SAVINASE by Novo Industries A/S (Denmark) and MAXATASE by International Bio-Synthetics, Inc. (The Netherlands).
  • proteases include Protease A (see European Patent Application 130,756 , published January 9, 1985) and Protease B (see European Patent Application Serial No. 87303761.8 , filed April 28, 1987, and European Patent Application 130,756 , Bott et al, published January 9, 1985).
  • Amylases include, for example, ⁇ -amylases described in British Patent Specification No. 1,296,839 (Novo), RAPIDASE, International Bio-Synthetics, Inc. and TERMAMYL, Novo Industries.
  • the cellulase usable in the present invention include both bacterial or fungal cellulase. Preferably, they will have a pH optimum of between 5 and 9.5.
  • Suitable cellulases are disclosed in U.S. Patent 4,435,307 , Barbesgoard et al, issued March 6, 1984, which discloses fungal cellulase produced from Humicola insolens and Humicola strain DSM1800 or a cellulase 212-producing fungus belonging to the genus Aeromonas, and cellulase extracted from the hepatopancreas of a marine mollusk (Dolabella Auricula Solander).
  • suitable cellulases are also disclosed in GB-A-2.075.028 ; GB-A-2.095.275 and DE-OS-2.247.832 . CAREZYME (Novo) is especially useful.
  • Suitable lipase enzymes for detergent usage include those produced by microorganisms of the Pseudomonas group, such as Pseudomonas stutzeri ATCC 19.154, as disclosed in British Patent 1,372,034 . See also lipases in Japanese Patent Application 53,20487 , laid open to public inspection on February 24, 1978. This lipase is available from Amano Pharmaceutical Co. Ltd., Nagoya, Japan, under the trade name Lipase P "Amano,” hereinafter referred to as "Amano-P.” Other commercial lipases include Amano-CES, lipases ex Chromobacter viscosum, e.g. Chromobacter viscosum var.
  • lipolyticum NRRLB 3673 commercially available from Toyo Jozo Co., Tagata, Japan; and further Chromobacter viscosum lipases from U.S. Biochemical Corp., U.S.A. and Disoynth Co., The Netherlands, and lipases ex Pseudomonas gladioli.
  • the LIPOLASE enzyme derived from Humicola lanuginosa and commercially available from Novo is a preferred lipase for use herein.
  • Peroxidase enzymes are used in combination with oxygen sources, e.g., percarbonate, perborate, persulfate, hydrogen peroxide, etc. They are used for "solution bleaching," i.e. to prevent transfer of dyes or pigments removed from substrates during wash operations to other substrates in the wash solution.
  • Peroxidase enzymes are known in the art, and include, for example, horseradish peroxidase, ligninase, and haloperoxidase such as chloro- and bromo-peroxidase.
  • Peroxidase-containing detergent compositions are disclosed, for example, in PCT International Application WO 89/099813 , published October 19, 1989, by O. Kirk, assigned to Novo Industries A/S.
  • Patent 3,600,319 issued August 17, 1971 to Gedge, et al, and European Patent Application Publication No. 0 199 405 , Application No. 86200586.5 , published October 29, 1986, Venegas.
  • Enzyme stabilization systems are also described, for example, in U.S. Patent 3,519,570 .
  • detergent compositions include chelating agents, soil release agents, soil antiredeposition agents, dispersing agents, suds suppressors, fabric softeners, dye transfer inhibition agents and perfumes.
  • the compounds disclosed above for a product are advantageously packed in a packaging system.
  • a packaging system may be formed from a sheet of flexible material.
  • Materials suitable for use as a flexible sheet include mono-layer, co-extruded or laminated films.
  • Such films may comprise various components, such as poly-ethylene, poly-propylene, poly-styrene. poly-ethylene-terephtalate.
  • the packaging system is composed of a poly-ethylene and bi-oriented-poly-propylene co-extruded film with an MVTR of less than 5 g/day/m 2 .
  • the MVTR of the packaging system is preferably of less than 10 g/day/m 2 , more preferably of less than 5 g/day/m 2 .
  • the film (2) may have various thicknesses. The thickness should typically be between 10 and 150 ⁇ m, preferably between 15 and 120 ⁇ m, more preferably between 20 and 100 ⁇ m, even more preferably between 25 and 80 ⁇ m and most preferably between 30 and 40 ⁇ m.
  • a packaging material preferably comprises a barrier layer typically found with packaging materials having a low oxygen transmission rate, typically of less than 300 cm 3 /m 2 /day, preferably of less than 150 cm 3 /m 2 /day, more preferably of less than 100 cm 3 /m 2 /day, even more preferably of less than 50 cm 3 /m 2 /day and most preferably of less than 10 cm 3 /m 2 /day.
  • Typical materials having such barrier properties include bi oriented polypropylene, poly ethylene terephthalate, Nylon, poly(ethylene vinyl alcohol) , or laminated materials comprising one of these, as well as SiOx (Silicium oxydes), or metallic foils such as aluminium foils for example.
  • Such packaging material may have a beneficial influence on the stability of the product during storage for example.
  • a longitudinal seal is provided, which may be a fin seal or an overlapping seal, after which a first end of the packaging system is closed with a first end seal, followed by closure of the second end with a second end seal.
  • the packaging system may comprise re-closing means as described in WO92/20593 .
  • a cold seal or an adhesive is particularly suited.
  • a band of cold seal or a band of adhesive may be applied to the surface of the packaging system at a position adjacent to the second end of the packaging system, so that this band may provide both the initial seal and re-closure of the packaging system.
  • the adhesive or cold seal band may correspond to a region having a cohesive surface, i.e. a surface which will adhere only to another cohesive surface.
  • Such re-closing means may also comprise spacers which will prevent unwanted adhesion.
  • spacers are described in WO 95/13225 , published on the 18 th of May 1995.
  • There may also be a plurality of spacers and a plurality of strips of adhesive material. The main requirement is that the communication between the exterior and the interior of the package should be minimal, even after first opening of the packaging system.
  • a cold seal may be used, and in particular a grid of cold seal, whereby the cold seal is adapted so as to facilitate opening of the packaging system.
  • % dispensing residue weight ⁇ x ⁇ 100 / original weight of both tablets .
  • Composition A (% by weight) Anionic agglomerates 1 21.5 Anionic agglomerates 2 13.0 Cationic agglomerates 5.5 Layered silicate 10.8 Sodium percarbonate 14.2 Bleach activator agglomerates 5.5 Sodium carbonate 10.98 EDDS/Sulphate particle 0.5 Tetrasodium salt of Hydroxyethane Diphosphonic acid 0.8 Soil Release Polymer 0.3 Fluorescer 0.2 Zinc Phthalocyanine sulphonate 0.02 Soap powder 1.4 Suds suppressor 1.9 Citric acid 7.1 Protease 0.8 Lipase 0.3 Cellulase 0.2 Amylase 1.0 Binder spray-on system 4 Anionic agglomerates 1 comprise of 40% anionic surfactant, 27% zeolite and 3
  • Ethylene diamine N,N-disuccinic acid sodium salt/Sulphate particle comprise of 58% of Ethylene diamine N,N-disuccinic acid sodium salt, 23% of sulphate and 19% water.
  • Zinc phthalocyanine sulphonate encapsulates are 10% active.
  • Suds suppressor comprises of 11.5% silicone oil (ex Dow Corning); 59% of zeolite and 29.5% of water.
  • Binder spray-on system comprises 25% of Lutensit K-HD 96 and 75% by weight of PEG (Poly Ethylene Glycol).
  • %dispensing for example 1 tablets was found to be 50%, whereas %dispensing for example 2 tablets was found to be 8%.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)

Claims (9)

  1. Verfahren zur Herstellung einer Detergenztablette, welches Verfahren einen ersten Schritt zur Bereitstellung einer Detergenzzusammensetzung, einen zweiten Schritt zur Ausbildung eines die Detergenzzusammensetzung umfassenden teilchenförmigen Materials, wobei eine Mischung aus einigen oder sämtlichen Komponenten des teilchenförmigen Materials mit einem nicht-gelierenden Bindemittel besprüht werden und einen dritten Schritt zur Komprimierung des teilchenförmigen Materials In eine Tablettenform umfasst, wobei das Verfahren dadurch gekennzeichnet ist, dass es ferner einen Schritt des Kühlens der Detergenzzusammensetzung unter Umgebungstemperatur zwischen dem ersten und dem dritten Schritt umfasst.
  2. Verfahren nach Anspruch 1, worin die Umgebungstemperatur mehr als 18°C beträgt.
  3. Verfahren nach einem der Ansprüche 1 oder 2, worin der Schritt des Kühlens der Detergenzzusammensetzung im Aussetzen der Detergenzzusammensetzung unter eine Temperatur unter Umgebungstemperatur in einem Raumabschnitt besteht.
  4. Verfahren nach Anspruch 3, worin das Aussetzen durch Stellen oder Verlagern der Detergenzzusammensetzung in oder durch den Raumabschnitt, in welchem die Temperatur unter Umgebungstemperatur liegt, während einer gegebenen Aussetzungsdauer erfolgt.
  5. Verfahren nach einem der Ansprüche 3 oder 4, worin die Temperaturdifferenz zwischen der Umgebungstemperatur und der Temperatur unter Umgebungstemperatur mindestens 3°C beträgt.
  6. Verfahren nach den beiden Ansprüchen 4 und 5, worin die Aussetzungsdauer zum Gewicht der ausgesetzten Detergenzzusammensetzung, dividiert durch die Temperaturdifferenz, proportional ist.
  7. Verfahren nach einem der vorstehenden Ansprüche, worin die Detergenzzusammensetzung mindestens 10 Gew.-% an grenzflächenaktivem Mittel umfasst.
  8. Verfahren nach einem der vorstehenden Ansprüche, worin die Detergenzzusammensetzung mindestens 2 Gew.-% an Bindemittel umfasst.
  9. Verfahren nach einen der vorstehenden Ansprüche, worin die Detergenzzusammensetzung nach dem Schritt des Kühlens und vor dem dritten Schritt eine Temperatur unter Umgebungstemperatur aufweist.
EP99870039A 1999-03-05 1999-03-05 Produktionsverfahren für Waschmitteltablette Expired - Lifetime EP1035197B2 (de)

Priority Applications (12)

Application Number Priority Date Filing Date Title
ES99870039T ES2177212T3 (es) 1999-03-05 1999-03-05 Procedimiento de produccion para comprimidos de detergente.
EP99870039A EP1035197B2 (de) 1999-03-05 1999-03-05 Produktionsverfahren für Waschmitteltablette
DE1999601873 DE69901873T3 (de) 1999-03-05 1999-03-05 Produktionsverfahren für Waschmitteltablette
BR0008775-0A BR0008775A (pt) 1999-03-05 2000-02-29 Processo de produção para tablete detergente
AU36128/00A AU3612800A (en) 1999-03-05 2000-02-29 Production process for detergent tablet
EP00914783A EP1159394A1 (de) 1999-03-05 2000-02-29 Produktionsverfahren für waschmitteltablette
US09/914,493 US6846794B1 (en) 1999-03-05 2000-02-29 Production process for detergent tablet
CA002362954A CA2362954A1 (en) 1999-03-05 2000-02-29 Production process for detergent tablet
JP2000602741A JP2002538269A (ja) 1999-03-05 2000-02-29 洗剤錠剤の製造方法
CN 00807115 CN1425059A (zh) 1999-03-05 2000-02-29 洗涤剂片的制备方法
PCT/US2000/005292 WO2000052129A1 (en) 1999-03-05 2000-02-29 Production process for detergent tablet
ARP000100959 AR022826A1 (es) 1999-03-05 2000-03-03 Proceso de produccion para tabletas de detergentes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99870039A EP1035197B2 (de) 1999-03-05 1999-03-05 Produktionsverfahren für Waschmitteltablette

Publications (3)

Publication Number Publication Date
EP1035197A1 EP1035197A1 (de) 2000-09-13
EP1035197B1 EP1035197B1 (de) 2002-06-19
EP1035197B2 true EP1035197B2 (de) 2010-03-03

Family

ID=8243804

Family Applications (2)

Application Number Title Priority Date Filing Date
EP99870039A Expired - Lifetime EP1035197B2 (de) 1999-03-05 1999-03-05 Produktionsverfahren für Waschmitteltablette
EP00914783A Withdrawn EP1159394A1 (de) 1999-03-05 2000-02-29 Produktionsverfahren für waschmitteltablette

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP00914783A Withdrawn EP1159394A1 (de) 1999-03-05 2000-02-29 Produktionsverfahren für waschmitteltablette

Country Status (10)

Country Link
EP (2) EP1035197B2 (de)
JP (1) JP2002538269A (de)
CN (1) CN1425059A (de)
AR (1) AR022826A1 (de)
AU (1) AU3612800A (de)
BR (1) BR0008775A (de)
CA (1) CA2362954A1 (de)
DE (1) DE69901873T3 (de)
ES (1) ES2177212T3 (de)
WO (1) WO2000052129A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090325841A1 (en) 2008-02-11 2009-12-31 Ecolab Inc. Use of activator complexes to enhance lower temperature cleaning in alkaline peroxide cleaning systems

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0771827A2 (de) † 1995-10-30 1997-05-07 Sekisui Kagaku Kogyo Kabushiki Kaisha Verfahren zur Herstellung von mit Silan modifizierten Polyolefinen und Extruder dafür
WO2000050548A2 (de) † 1999-02-25 2000-08-31 Henkel Kommanditgesellschaft Auf Aktien Verfahren zur herstellung schnell zerfallender wasch- und reinigungsmittelformkörper

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3371977B2 (ja) * 1993-01-12 2003-01-27 花王株式会社 錠剤型洗剤の製造方法
US5759976A (en) * 1993-09-13 1998-06-02 Diversey Lever, Inc. Process for forming tableted high-caustic detergent
GB9422925D0 (en) * 1994-11-14 1995-01-04 Unilever Plc Detergent compositions
GB9422924D0 (en) * 1994-11-14 1995-01-04 Unilever Plc Detergent compositions
EP0896052A1 (de) * 1997-08-08 1999-02-10 The Procter & Gamble Company Waschmitteltablette

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0771827A2 (de) † 1995-10-30 1997-05-07 Sekisui Kagaku Kogyo Kabushiki Kaisha Verfahren zur Herstellung von mit Silan modifizierten Polyolefinen und Extruder dafür
WO2000050548A2 (de) † 1999-02-25 2000-08-31 Henkel Kommanditgesellschaft Auf Aktien Verfahren zur herstellung schnell zerfallender wasch- und reinigungsmittelformkörper

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
W.HERMAN DE GROOT: "The Manufacture of Modern Detergent Powder", 1995, HERMAN DE GROOT ACADEMIC PUBLISHER, WASSENAAR, THE NEDERLANDS, ISBN: 90-9008464-9, pages: 113 - 127 †

Also Published As

Publication number Publication date
DE69901873T2 (de) 2003-02-20
ES2177212T3 (es) 2002-12-01
AR022826A1 (es) 2002-09-04
EP1035197A1 (de) 2000-09-13
CA2362954A1 (en) 2000-09-08
DE69901873D1 (de) 2002-07-25
JP2002538269A (ja) 2002-11-12
BR0008775A (pt) 2001-12-26
EP1035197B1 (de) 2002-06-19
EP1159394A1 (de) 2001-12-05
CN1425059A (zh) 2003-06-18
AU3612800A (en) 2000-09-21
WO2000052129A1 (en) 2000-09-08
DE69901873T3 (de) 2010-09-23

Similar Documents

Publication Publication Date Title
EP0971028A1 (de) Waschmitteltablette mit hoher Löslichkeit und verbesserten mechanischen Eigenschaften
EP1026228B1 (de) Beschichtetes Reinigungsmittel in Tablettenform
US6846794B1 (en) Production process for detergent tablet
EP1149153A1 (de) Beschichtetes reinigungsmittel in tablettenform
EP0999262A1 (de) Mehrschichtwaschmitteltabletten
EP0979863A1 (de) Mehrschichtwaschmitteltablette mit unterschiedlicher Elastizität
EP0971029B1 (de) Waschmitteltablette mit hohen mechanischen und Lösungseigenschaften
EP1035197B2 (de) Produktionsverfahren für Waschmitteltablette
EP1026227A1 (de) Beschichtetes Reinigungsmittel in Tablettenform
US20030114349A1 (en) Coating composition for solid bodies
EP0999261A1 (de) Farbige Tablette
EP0979862A1 (de) Mehrschichtwaschmitteltabletten mit unterschiedlicher Härte
EP0949327A1 (de) Form und Festigkeit von Waschmitteltabletten
EP1072674A1 (de) Beschichtetes Reinigungsmittel in Tablettenform
EP1149896A1 (de) Beschichtungszusammensetzung für Festkörper
WO2001025391A1 (en) Detergent tablet with high dissolution and mechanical characteristics
CA2336953A1 (en) Process for producing a powder from a packaged tablet
MXPA01008953A (en) Production process for detergent tablet
EP0990592A1 (de) Packung mit einem Entlüftungssystem

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE ES FR GB IT NL

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

17P Request for examination filed

Effective date: 20010312

AKX Designation fees paid

Free format text: AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

17Q First examination report despatched

Effective date: 20011206

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

RBV Designated contracting states (corrected)

Designated state(s): DE ES FR GB IT NL

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): DE ES FR GB IT NL

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 69901873

Country of ref document: DE

Date of ref document: 20020725

ET Fr: translation filed
REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2177212

Country of ref document: ES

Kind code of ref document: T3

PLBI Opposition filed

Free format text: ORIGINAL CODE: 0009260

PLBF Reply of patent proprietor to notice(s) of opposition

Free format text: ORIGINAL CODE: EPIDOS OBSO

26 Opposition filed

Opponent name: HENKEL KGAA

Effective date: 20030303

NLR1 Nl: opposition has been filed with the epo

Opponent name: HENKEL KGAA

PLBB Reply of patent proprietor to notice(s) of opposition received

Free format text: ORIGINAL CODE: EPIDOSNOBS3

APBP Date of receipt of notice of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA2O

APBM Appeal reference recorded

Free format text: ORIGINAL CODE: EPIDOSNREFNO

APBQ Date of receipt of statement of grounds of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA3O

APAH Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNO

APBU Appeal procedure closed

Free format text: ORIGINAL CODE: EPIDOSNNOA9O

PLAY Examination report in opposition despatched + time limit

Free format text: ORIGINAL CODE: EPIDOSNORE2

PLBC Reply to examination report in opposition received

Free format text: ORIGINAL CODE: EPIDOSNORE3

PLAB Opposition data, opponent's data or that of the opponent's representative modified

Free format text: ORIGINAL CODE: 0009299OPPO

R26 Opposition filed (corrected)

Opponent name: HENKEL AG & CO. KGAA

Effective date: 20030303

NLR1 Nl: opposition has been filed with the epo

Opponent name: HENKEL AG & CO. KGAA

PUAH Patent maintained in amended form

Free format text: ORIGINAL CODE: 0009272

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: PATENT MAINTAINED AS AMENDED

27A Patent maintained in amended form

Effective date: 20100303

AK Designated contracting states

Kind code of ref document: B2

Designated state(s): DE ES FR GB IT NL

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20100323

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20100323

Year of fee payment: 12

Ref country code: FR

Payment date: 20100318

Year of fee payment: 12

REG Reference to a national code

Ref country code: NL

Ref legal event code: VDEP

Effective date: 20100304

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20100308

Year of fee payment: 12

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100304

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100614

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20110331

Year of fee payment: 13

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20111130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20110331

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20110305

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20120227

Year of fee payment: 14

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 69901873

Country of ref document: DE

Effective date: 20121002

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20130305

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130305

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20121002